Mural Oncology plc Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
0M
-
0M
0M
196M
31M
166M
-196M
0M
-195M
12M
-207M
3.71%
0M
0M
0M
3M
0M
0M
-
0M
0M
195M
25M
170M
-195M
0M
-195M
5M
-200M
14.02%
195M
0M
-194M
2M
-195M
0M
-
0M
0M
175M
16M
160M
-175M
0M
-175M
0M
-175M
14.02%
175M
0M
-174M
1M
-175M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
4Q2022
3Q2022
0M
-
0M
0M
59M
16M
42M
-59M
0M
-58M
2M
-60M
14.02%
0M
0M
0M
1M
0M
0M
-
0M
0M
46M
6M
40M
-46M
0M
-46M
5M
-51M
14.02%
46M
0M
-46M
1M
-46M
0M
-
0M
0M
58M
12M
45M
-58M
0M
-58M
1M
-59M
14.02%
58M
0M
-57M
0M
-58M
0M
-
0M
0M
49M
5M
45M
-49M
0M
-49M
1M
-51M
14.02%
49M
0M
-49M
0M
-49M